Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity

Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity

Saved in:

Bibliographic Details
Main Authors:	Jae Hyun Bae, Young Min Cho
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Series:	Journal of Diabetes Investigation
Online Access:	https://doi.org/10.1111/jdi.14336
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beyond incretins: targeting neurokinin receptors for obesity treatment
by: Doreen Thor, et al.
Published: (2025-01-01)

The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature
by: Jakub Waszczyński, et al.
Published: (2025-01-01)

The Impact of Incretin-Based Medications on Lipid Metabolism
by: Habib Yaribeygi, et al.
Published: (2021-01-01)

Impact of Incretin-Based Therapies on Adipokines and Adiponectin
by: Habib Yaribeygi, et al.
Published: (2021-01-01)

Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis
by: Song Liu, et al.
Published: (2025-02-01)

Triple Incretin Agonists in Diabetes Mellitus: Retatrutide Improves Lipid Profile and Decreases Blood Pressure
by: Nuri Barış Hasbal, et al.
Published: (2025-01-01)

Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
by: AJin Cho, et al.
Published: (2020-01-01)

The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity
by: Ying Wang, et al.
Published: (2025-02-01)

The Role of Big Data Analytics in Revolutionizing Diabetes Management and Healthcare Decision-Making
by: Muhammad Nauman, et al.
Published: (2025-01-01)

The Effect of Whey Protein Consumption on Postprandial Glucose, Insulin and Incretin Responses in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Acute-Term Controlled Clinical Trials
by: Zahra Salimi, et al.
Published: (2025-02-01)

Current treatment landscape for obesity in Singapore
by: Phong Ching Lee, et al.
Published: (2023-03-01)

Revolutionizing healthcare delivery with blockchain technology
by: S Saravanan
Published: (2024-09-01)

Revolutionizing Diabetic Retinopathy Screening: Integrating AI-Based Retinal Imaging in Primary Care
by: Dean Beals, et al.
Published: (2025-12-01)

The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
by: Fernando Cordido, et al.
Published: (2010-01-01)

Revolutionizing industrial automation with wireless sensor networkis
by: Rita de Fátima Muniz, et al.
Published: (2023-09-01)

iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01)

Apoptosis in the liver of male <em>db/db</em> mice during the development of obesity and type 2 diabetes
by: S. V. Michurina, et al.
Published: (2020-07-01)

Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
by: Kader Ugur, et al.
Published: (2019-01-01)

The Hormonal dysregulation and its consequences in Obese Women - overview
by: Katarzyna Maria Pala, et al.
Published: (2025-01-01)

Editorial: Exploring the future of neurology: how AI is revolutionizing diagnoses, treatments, and beyond
by: Rafeed Alkawadri, et al.
Published: (2025-02-01)

Artificial intelligence as a factor revolutionizing higher education
by: Yu. B. Melnyk, et al.
Published: (2024-06-01)

Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
by: Yuanjie Mao, et al.
Published: (2025-01-01)

Genetics of Obesity and Type 2 Diabetes in African Americans
by: Shana McCormack, et al.
Published: (2013-01-01)

Type 2 Diabetes Mellitus and its Relationship with Obesity
by: Lina Neri Espinosa Pire, et al.
Published: (2025-01-01)

Plasma Adiponectin and Its Correlation with Carotid Intima-Media Thickness in Obesity and in Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
by: Maha Hussein, et al.
Published: (2023-01-01)

Transcriptomic landscape of hyperthyroidism in mice overexpressing thyroid-stimulating hormone
by: Ichiro Yamauchi, et al.
Published: (2025-02-01)

Obesity Related Alterations in Plasma Cytokines and Metabolic Hormones in Chimpanzees
by: Pramod Nehete, et al.
Published: (2014-01-01)

Body Weight Control by a High-Carbohydrate/Low-Fat Diet Slows the Progression of Diabetic Kidney Damage in an Obese, Hypertensive, Type 2 Diabetic Rat Model
by: Shuichi Ohtomo, et al.
Published: (2010-01-01)

Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations
by: Alireza Shadab, et al.
Published: (2025-02-01)

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies
by: Ugochi Ebinama, et al.
Published: (2025-01-01)

Liver Damage in Type 1 Diabetes Mellitus
by: A. O. Bueverov, et al.
Published: (2021-06-01)

Effects of Short Term Exposure of Atrazine on the Liver and Kidney of Normal and Diabetic Rats
by: Dinesh Babu Jestadi, et al.
Published: (2014-01-01)

Revolutionizing Mental Health: Innovations, Technology, and Wellness in the Digital Age
by: Ram Kumar Garg
Published: (2024-01-01)

Obesity-Related Chronic Kidney Disease: From Diagnosis to Treatment
by: Elena Avgoustou, et al.
Published: (2025-01-01)

Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity
by: Astrid Kolderup, et al.
Published: (2015-01-01)

Role of Tissue and Systemic Hypoxia in Obesity and Type 2 Diabetes
by: Lei Xi, et al.
Published: (2016-01-01)

Effects on the sex hormone profile in obese patients undergoing bariatric surgery
by: Ana I. López, et al.
Published: (2023-07-01)

Positive association between proinsulin and fatty liver index in people with type 2 diabetes
by: Akinobu Nakamura, et al.
Published: (2024-02-01)

Creatinine-Based Estimations of Kidney Function Are Unreliable in Obese Kidney Donors
by: Nidhi Aggarwal, et al.
Published: (2012-01-01)

Growth Hormone Therapy for Small for Gestational Age Short Stature Develops Type 2 Diabetes
by: Naohiro Nomura, et al.
Published: (2023-01-01)